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List of abbreviations
List of abbreviations
3D Three-dimensional 
ACTA2, αSMA Aorta smooth muscle actin α 2
ACVR2A ACTIVIN A receptor type IIA
ACVR2B ACTIVIN A receptor type IIB
ACVRL (ALK) ACTIVIN A receptor-like kinase
Ad Adenovirus 
AFP α-fetoprotein 
AKT V-akt murine thymoma viral oncogene homolog
ALD Alcoholic liver disease 
ALDH1A1 Aldehyde dehydrogenase 1 family, member A1
ALK1Fc/ ACE-041 Activin receptor-like kinase-1- fragment crystallised region 
ALK5 Activin receptor-like kinase-5 
AMH Anti-Mullerian hormone 
AMSH SH3 domain of signal transducing adaptor molecule
AON Antisense oligonucleotide
AP-1 Activator protein 1
ARKADIA Ring finger protein 11 
BAM (BCL-XL) BCL-2 associated agonist of cell death
BAMBI BMP and ACTIVIN membrane-bound inhibitors
bFGF Basic fibroblast growth factor 
BIM; BCL-2-like 11
BMI-1 B cell-specific Moloney murine leukemia virus integration site 1
BMP Bone morphogenetic protein
BMPR BMP receptor 
BRE BMP-response-element
CAGA Cytosine adenine guanine adenine 
CASP3 Cleaved caspase 3 
CBP (TRX) cAMP response element-binding protein, Trithorax protein 
CCl4 Carbon tetrachloride 
CDC42 Cell division cycle 42
CDK Cyclin-dependent kinases 
CDK4 Cyclin-Dependent Kinase 4
CDKN1A (p21) Cyclin-dependent kinase inhibitor 1A
CDKN1B (p27KIP1) Cyclin-dependent kinase inhibitor 1B
CDKN2B (p15INK2B) Cyclin-dependent kinase inhibitor 2B
cDNA Complementary DNA 
CFc Control Fc 
C-FOS Cellular FBJ (Finkel-Biskis-Jinkins) Murine Osteosarcoma viral oncogene homolog
C-JUN Cellular- ju-nana (Abbreviated from Japanese,the number 17); derived from the ASV 17 provirus.
Ck19 Cytokeratin 19 
CMYC V-myc avian myelocytomatosis viral oncogene homolog
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COL1A1 Collagen type 1 α 1
COL1A2 Collagen type 1 α 2
co-SMAD Common mediator SMAD (SMAD4)
c-SRC Avian sarcoma (Schmidt-Ruppin A2) viral oncogene
CTGF/CCN2 Connective tissue growth factor 
CV Central vein
DAPPER2 Dishevelled-binding antagonist of β-catenin
DCN Decorin 
DD Dupuytren’s disease 
DDCt Delta-delta cycle threhold algorithm 
DNA Deoxyribonucleic acid 
DNDM DNA demethylating complex 
E1A Adenovirus early gene1 
E2F Elongation factor-2 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EGF-CFC EGF-like, cysteine-rich CRIPTO-FRL1-CRYPTIC 
EMT epithelial-to-mesenchymal transition 
ERG v-ets avian erythroblastosis virus E26 oncogene homolog
ERK Mitogen-activated protein kinase 1
ERK Extracellular signal-regulated kinase
FKBP12 Inhibitor FK506-binding protein 
FN Fibronectin 
FOX Forkhead Box 
FOXH1 Forkhead Box H1
GADD34 Growth arrest and DNA damage protein 
GADD45B Growth arrest and DNA-damage-inducible 45 beta
GATA3 GATA binding protein 3 
GC Guanine cytosine
GDF Growth and differentiation factors 
GPI Glucophosphatidylinositol
GRP-78 Glucose-related protein-78
GS Glycine-serine
GSK3 Glycogen Synthase Kinase 3
GTPase Guanosinetriphosphatase
HBV/ HCV Viral hepatitis B/ C
HCC Hepatocellular carcinoma 
HDACs Histone Deacetylases
HHT Hereditary telangiectasia 
HMGA2 High motility group AT-hook 2 protein
HSCs Hepatic stellate cells 
ID Inhibitor of differentiation
IKBa Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha,
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I-SMAD Inhibitory SMAD
JAG1 Jagged 1 
JNK C-Jun N-terminal kinase
JUNB Jun B proto-oncogene
LAP Latency-associated peptide 
LEF Lymphoid enhancer-binding factor
LLC Large latency complex 
LRP5 Leucine-rich protein 5
LTBP Latent TGFβ binding protein 
luc Firefly luciferase 
MAPK Mitogen-activated protein kinase
MEK MAPK/ERK
MET Mesenchymal-to-epithelial transition 
MFBs Myofibroblasts
MH1, 2 MAD homology 1, 2 domain 
miRNA Micro ribonucleic acid
MMP Matrix metalloprotease 
mRNA Messenger RNA 
mTOR Mammalian target of rapamycin
MYO-D Myogenic differentiation antigen 
NICD Notch intracellular domain 
NKX2.5 NK 2 homeobox 5
NR4A1 Nuclear Receptor Subfamily 4, Group A, Member 1
NT Non targeting 
OCT4 Octamer-binding transcription factor 4
ODN Oligodeoxynucleotide
OSX Osterix  (Sp7 transcription factor)
p38 Mitogen-activated protein kinase 14
p53 tumor protein p53 
PACE-4 Paired basic amino acid cleaving enzyme-4
PAI-1 Plasminogen activator inhibitor 1
PAR6 Par-6 family cell polarity regulator
PCa Prostate cancer
PCNA Proliferating nuclear antigen 
PDGFβ Platelet derived growth factor β polypeptide
PH3 Phosphorylated histone 3 
PI3K Phosphoinositole-3 kinase 
PP1,2 Protein phosphatase 
PTEN Phosphatase and tensin homolog
PTM Post translational modification 
PV Portal vein 
qRT-PCR Quantititative real time polymerase chain reaction 
RAC Rho Family, small GTP binding protein
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RAF Virus-induced rapidly accelerated fibrosarcoma
RAS Retrovirus-associated DNA sequences
RBP-Jk Recombination signal binding protein for immunoglobulin kappa J region
Ren Renilla luciferase
RGM Repulsive guidance molecule
RHO Rhodopsin
RLU Relative light units (luc/ ren)
R-SMAD Receptor-activated SMAD
RTK Receptor tyrosine kinase 
RUNX Runt-related protein 
Ser Serine 
SHG Second harmonic generation 
shRNA Short hairpin RNA 
SKI Avian sarcoma viral (v-ski) oncogene
SLC Small latency complex
SMAD Small mothers against decapentaplegic 
SMI Small molecule inhibitor 
SMURF SMAD specific E3 ubiquitin protein ligase
SNAIL Snail family zinc finger protein,
SNON SKI-related oncogene 
SOX2 Sry-related HMG box protein 2 
SP1 Specificity protein-1 
SRE SMAD-response element
SWI/SNF SWItch/Sucrose non-fermentable 
TAK1 TGFβ-associated kinase 1 
TDGF1 Teratocarcinoma-derived growth factor 
TGFa Transforming growth factor alpha 
TGFβ Transforming growth factor β
TGIF TGFβ-induced homeobox factor
Thr Threonine
TIMPs Tissue inhibitor of metalloproteinase 1
TMPRSS2-ERG transmembrane protease, serine 2
TOPRO TO-PRO-3 nuclear dye 
TP53 tumor protein p53 
TPF Two photon excited fluorescence 
TRAF6 TNFα-associated factor 6
TSP-1 Thrombospondin-1
TWIST Twist family BHLH transcription factor
Tyr Tyrosine
TβRI Transforming growth factor β receptor type I
TβRII Transforming growth factor β receptor type II
VEGF Vascular endothelial growth factor 
ViM Vivo-morpholino
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WNT Wingless-Type factor 
X any aminoacid
ZEB zinc finger E-box binding homeobox
ZO-1 Tight junction protein 1
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“Nothing behind me, everything ahead of me, 
as is always so on the road”. 
Jack Kerouaq 
On the road, 1957

